Wednesday, February 10, 2010, 8:43am EST - Canadian Markets open in 47 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Bio-Matrix Scientific Group, Inc. (BMSN.OB)

On Feb 9: 0.065 USD   0.00 (0.00%)  
MORE ON BMSN.OB
Quotes
Charts
News & Info
HereHeadlines
Company
Analyst Coverage
Ownership
Financials
Headlines Get Headlines for:
Tue, Feb 9, 2010
BIO-MATRIX SCIENTIFIC GROUP, INC. Files SEC form 10-Q, Quarterly Report
EDGAR Online (Tue 6:00am)
Tue, Feb 2, 2010
Bio-Matrix Scientific Group's Majority Owned Subsidiary Entest BioMedical Initiates Studies to Support Stem Cell / Laser Regenerative Therapy for COPD
Marketwire (Tue, Feb 2)
Thu, Jan 28, 2010
Bio-Matrix Scientific Group, Inc.'s Majority Owned Subsidiary Entest BioMedical, Inc. to Be Featured on Stem Cell Pioneers "Ask the Doctor" Forum Discussing the Company's Progress on Its COPD Stem Cell / Laser Therapy
Marketwire (Thu, Jan 28)
Fri, Jan 22, 2010
Entest BioMedical Projecting Near Term Start Up of Study on Stem Cell and Laser Treatment for COPD at Bio-Matrix Scientific Group's Stem Cell Research Facility
Marketwire (Fri, Jan 22)
Wed, Jan 20, 2010
BIO-MATRIX SCIENTIFIC GROUP, INC. Financials
EDGAR Online Financials (Wed, Jan 20)
Thu, Jan 14, 2010
BIO-MATRIX SCIENTIFIC GROUP, INC. Files SEC form 10-K, Annual Report
EDGAR Online (Thu, Jan 14)
Tue, Jan 12, 2010
Entest BioMedical Inc. (OTCBB: ENTB) Obtains Specimen to Be Used in Immunotherapeutic Cancer Vaccine Research
Marketwire (Tue, Jan 12)
Fri, Jan 8, 2010
BIO-MATRIX SCIENTIFIC GROUP, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year
EDGAR Online (Fri, Jan 8)
Tue, Jan 5, 2010
BIO-MATRIX SCIENTIFIC GROUP, INC. Files SEC form 8-K/A, Changes in Registrant's Certifying Accountant
EDGAR Online (Tue, Jan 5)
Wed, Dec 30, 2009
Entest BioMedical Files Grant Application With the National Heart, Lung and Blood Institute for Development of the Company's ENT-576 Laser Device for Treatment of COPD
Marketwire (Wed, Dec 30)
Wed, Nov 18, 2009
Entest BioMedical Files 3rd Patent Application for COPD Stem Cell Treatment New Patent Application covers technology to re-direct auto-immune related
PRNewswire (Wed, Nov 18)
Thu, Sep 10, 2009
BIO-MATRIX SCIENTIFIC GROUP, INC. Files SEC form 8-K/A, Changes in Registrant's Certifying Accountant
EDGAR Online (Thu, Sep 10)
Tue, Aug 25, 2009
BIO-MATRIX SCIENTIFIC GROUP, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statement
EDGAR Online (Tue, Aug 25)
BIO-MATRIX SCIENTIFIC GROUP, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statement
EDGAR Online (Tue, Aug 25)
Fri, Aug 21, 2009
BIO-MATRIX SCIENTIFIC GROUP, INC. Files SEC form 10-Q, Quarterly Report
EDGAR Online (Fri, Aug 21)
BIO-MATRIX SCIENTIFIC GROUP, INC. Files SEC form 10-Q, Quarterly Report
EDGAR Online (Fri, Aug 21)
Wed, Aug 12, 2009
BIO-MATRIX SCIENTIFIC GROUP, INC. Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statem
EDGAR Online (Wed, Aug 12)
Mon, Jun 22, 2009
BIO-MATRIX SCIENTIFIC GROUP, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Ma
EDGAR Online (Mon, Jun 22)
Fri, Jun 5, 2009
BIO-MATRIX SCIENTIFIC GROUP, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events
EDGAR Online (Fri, Jun 5)
Thu, May 7, 2009
BIO-MATRIX SCIENTIFIC GROUP, INC. Files SEC form 10-Q, Quarterly Report
EDGAR Online (Thu, May 7)
Older Headlines
View headlines from:

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Headlines for Another Symbol:
Symbol Lookup
Latest News Canadian Indices